Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Notice on the Supplementary Situation of Publicized Drugs in Hebei Province

Notice on the Supplementary Situation of Publicized Drugs in Hebei Province

ECHEMI 2019-05-15

Notice-on-the-Supplementary-Situation-of-Publicized-Drugs-in-Hebei-Province

According to the centralized procurement of drugs throughout the province, from April 28, 2019 to May 8, the approved pharmaceutical and manufacturing enterprises were publicized and questioned and clarified. Please login to Hebei Pharmaceutical Centralized Purchasing Network, enter the drug approval platform with user name and password, and check it in the "Internal Notification Bulletin" column.

Question and clarification materials should be related documents, approval, explanation, screenshot of official website, etc. If the material is unrecognizable or forged, all the consequences will be borne by the enterprise itself. Drugs whose quotation is lower or equal to the lowest networking/winning bid price of other provinces (cities) are publicized by networking; drugs whose quotation is higher than the lowest networking/winning bid price of other provinces (cities) are disqualified from networking; drugs whose price has not been inquired into are suspended for the time being. Enterprises are allowed to make complaints and then verify them according to their complaints.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.